NumerixS Investment Technologies’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-310
Closed -$29K – 1230
2019
Q4
$29K Buy
+310
New +$26K 0.01% 898
2019
Q1
– Sell
-2,300
Closed -$118K – 1292
2018
Q4
$118K Buy
+2,300
New +$135K 0.04% 514
2018
Q2
– Sell
-3,600
Closed -$128K – 1319
2018
Q1
$128K Buy
3,600
+3,500
+3,500% +$123K 0.03% 572
2017
Q4
$4K Buy
+100
New +$3.62K ﹤0.01% 1088
2017
Q3
– Sell
-4,800
Closed -$199K – 1311
2017
Q2
$199K Buy
4,800
+1,900
+66% +$72.2K 0.03% 639
2017
Q1
$102K Buy
2,900
+2,400
+480% +$76K 0.01% 886
2016
Q4
$15K Sell
500
-1,600
-76% -$49.5K ﹤0.01% 1048
2016
Q3
$63K Buy
+2,100
New +$63.4K 0.01% 923

Other funds holding RGEN

NumerixS Investment Technologies's RGEN Position: Q1 2020 in Review

NumerixS Investment Technologies sold out of Repligen (RGEN) in Q1 2020, closing a stake of 310 shares — an estimated $29K sold.

NumerixS Investment Technologies first reported a position in RGEN in Q3 2016 and held it in 8 quarters. The position peaked at $199K in Q2 2017. 309 funds tracked by Wall St. Rank hold RGEN as of Q1 2020.

  • NumerixS Investment Technologies reported no remaining Repligen position as of Q1 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 310 Repligen shares in Q1 2020, an estimated $29K.
  • NumerixS Investment Technologies first reported a position in Repligen in Q3 2016 and held it in 8 quarters.
  • NumerixS Investment Technologies's Repligen position peaked at $199K in Q2 2017.
  • 309 funds tracked by Wall St. Rank held Repligen as of Q1 2020.

Based on NumerixS Investment Technologies's 13F filing for Q1 2020, filed 15 May 2020.